13.02.2018 • NewsGemini PharmChemPeople

Thomas Buettner Succeeds Josef Goetz as managing director of Gemini PharmChem

Thomas W. Buettner has succeeded Josef Goetz as managing director of Gemini...
Thomas W. Buettner has succeeded Josef Goetz as managing director of Gemini PharmChem Mannheim (c) AlessaChemie

Thomas W. Buettner has succeeded Josef Goetz as managing director of Gemini PharmChem Mannheim in October. Born in Frankfurt in 1956, the lawyer looks back on more than 30 years of experience in the chemical industry. After he received his doctorate he worked at chemical companies Rütgers, Weylchem and AllessaChemie, where he was most recently CEO. Josef Goetz, a long-time managing director at the Mannheim, Germany, location, will be retained by the company as head of the pilot plant. The management is rounded off by Ivan Lugovoi (CFO and Investor Relations).

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.